首页> 外文会议>Conference on scale-up and manufacturing of cell-based therapies V >EXPANSION OF 3D HUMAN INDUCED PLURIPOTENT STEM CELL AGGREGATES IN BIOREACTORS: BIOPROCESS INTENSIFICATION AND SCALING-UP APPROACHES
【24h】

EXPANSION OF 3D HUMAN INDUCED PLURIPOTENT STEM CELL AGGREGATES IN BIOREACTORS: BIOPROCESS INTENSIFICATION AND SCALING-UP APPROACHES

机译:3D人类诱导的生物反应器中的3D人诱导多能干细胞聚集体:生物过程强化和缩放方法

获取原文

摘要

Human induced pluripotent stem cells (hiPSC) are attractive tools for drug screening and disease modeling and promising candidates for cell therapy applications. However, to achieve the high numbers of cells required for these purposes, scalable and clinical-grade technologies must be established. In this study, we use environmentally controlled stirred-tank bioreactors operating in perfusion as a powerful tool for bioprocess intensification of hiPSC production. We demonstrate the importance of controlling the dissolved oxygen concentration at low levels (4% oxygen) and perfusion at 1.3 day~(-1) dilution rate to improve hiPSC growth as 3D aggregates in xeno-free medium (Cellartis? DEF-CS~(TM) 500 Xeno-Free Culture Medium). This strategy allowed for increased cell specific growth rate, maximum volumetric cell concentrations (4.7x10~6 cell/mL) and expansion factors (approximately 19), resulting in an overall improvement of 2.6-fold in cell yields. Extensive cell characterization, including whole proteomic analysis was performed to confirm that the pluripotent phenotype was maintained during culture.
机译:人诱导多能干细胞(HIPSC)是用于药物筛查和疾病建模和对细胞疗法应用候选人的吸引力的工具。然而,为了达到这些目的所需的大量单元,必须建立可扩展和临床级技术。在这项研究中,我们使用环境控制的搅拌罐生物反应器,以灌注为一种强大的生物过程强化肝脏生产工具。我们证明了在1.3天〜(-1)稀释率下控制低水平(4%氧)(4%氧)和灌注的重要性,以改善无叶培养基中的3D聚合物(Cellartis?Def-Cs〜( TM)500种无异酚培养基)。该策略允许提高细胞特异性生长速率,最大体积细胞浓度(4.7×10〜6个细胞/ mL)和膨胀因子(约19),导致细胞产率的总体改善2.6倍。进行广泛的细胞表征,包括整个蛋白质组学分析以确认在培养过程中保持多能表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号